<DOC>
	<DOCNO>NCT01433042</DOCNO>
	<brief_summary>Study hypothesis : PillCam SB3 new capsule design provide improve image quality , improve SB duodenum tissue coverage due Adaptive Frame Rate ( AFR ) 2-6 fps , create image evaluation , therefore improve diagnostic accuracy . Proposed Design : enroll 230 patient symptoms suggest presence small bowel disease . Preparation procedure include 12 hour fast prior capsule ingestion Patients undergo standard capsule endoscopy . Patients allow drink clear liquid 2 hour post ingestion , eat 4 hour post ingestion . Diagnostic yield SB3 calculate The Physician 's subjective assessment capsule performance capture</brief_summary>
	<brief_title>PillCam SB3 Capsule- Feasibility Study</brief_title>
	<detailed_description>- Purpose study- To assess performance PillCam SB3 capsule detect small bowel lesion patient - Study design- Feasibility study - Number subjects- Up 200 - Subject population- Patients symptom suggestive small bowel disease eligible indicated SB capsule endoscopy - No centers- 4 - Duration enrollment 12 month IRB approval enroll study patient - Duration follow-up 1 week capsule procedure . - Primary objective To evaluate performance SB-3 system patient per physician questionnaire</detailed_description>
	<criteria>Inclusion criterion : 1 . Patient age â‰¥ 18 year old , 2 . Patients history suggestive /OR symptom suggestive small bowel disease eligible indicated SB capsule endoscopy , 3 . Patient and/or legal guardian able agree sign Informed Consent Form Exclusion criteria 1 . Patient dysphagia , 2 . Patient know suspect suffer intestinal obstruction , 3 . Patient know previous stricture/obstruction SB colon , 4 . Patient cardiac pacemaker implant electro medical device , 5 . Women either pregnant nursing time screening , intend study period , childbearing potential practice medically acceptable method contraception , 6 . Patient expect undergo MRI examination within 7 day ingestion capsule , 7 . Patient prior abdominal surgery gastrointestinal tract uncomplicated procedure would unlikely lead bowel obstruction base clinical judgment investigator , 8 . Patient condition , preclude compliance study and/or device instruction , 9 . Patient suffers life threaten condition , 10 . Patient currently participate another clinical study , 11 . Patient know slow gastric emptying time</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>small bowel disease</keyword>
</DOC>